-
Hi, sir. Thank you for the opportunity. So, sir, can you just please share what are some of the key hospital chains in which Aequitas is currently empanelled, and that you believe will be key drivers of your growth that you envisage for the next few years, and also the geographies in which these hospitals are located?
Read in transcript -
Right. And so these are the top customers from which you are envisioning the next two years of growth from Aequitas, right?
Read in transcript -
So, in the prior quarters, I believe the management had hinted at some first-in-India or breakthrough molecule pipeline. Can you please shed some light on the developments on the same if you have any?
Read in transcript
Analyst questions
Vansh Gupta
Prescient Capital
2Calls
1Company
JAGSNPHARM
All company callsJagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited
30 Jul 2026
Jagsonpal Pharmaceuticals Limited
30 Jul 2026
-
Hi, sir. Thank you for the opportunity. So, sir, can you just please share what are some of the key hospital chains in which Aequitas is currently empanelled, and that you believe will be key drivers of your growth that you envisage for the next few years, and also the geographies in which these hospitals are located?
Read in transcript -
Right. And so these are the top customers from which you are envisioning the next two years of growth from Aequitas, right?
Read in transcript -
So, in the prior quarters, I believe the management had hinted at some first-in-India or breakthrough molecule pipeline. Can you please shed some light on the developments on the same if you have any?
Read in transcript